Biofrontera Inc. 8-K

What Happened
Biofrontera Inc. announced its financial and operational results for the fourth quarter and fiscal year ended December 31, 2025 in a press release dated March 19, 2026. The company furnished that press release as Exhibit 99.1 to its Form 8‑K (filed March 19, 2026). The release includes non‑GAAP financial measures and provides reconciliations to the most directly comparable GAAP measures in accordance with Regulation G.

Key Details

• Press release dated March 19, 2026 announcing Q4 and fiscal‑year results for the period ended December 31, 2025.
• The Form 8‑K was filed under Item 2.02 (Results of Operations and Financial Condition).
• The press release contains non‑GAAP financial measures and quantitative reconciliations to GAAP measures per Regulation G.
• The press release is furnished as Exhibit 99.1 to the Form 8‑K.

Why It Matters
This filing provides investors with Biofrontera’s latest quarterly and annual earnings information and any operational updates the company chose to disclose. Because the release includes non‑GAAP measures, investors should review the provided reconciliations to understand how those figures relate to GAAP earnings and revenue. The information may influence investor assessments of recent revenue and profitability trends for Biofrontera.